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Abstract
Background: Norovirus (NoV) has been recognized as the leading cause of both outbreaks and sporadic cases of
acute gastroenteritis in children and adults worldwide. Stool samples collected from outpatients with clinical
symptoms of acute gastroenteritis in all age groups at the First People’s Hospital in Huzhou, Huzhou, China
between March 2014 and February 2015 were analyzed to gain insight into the epidemiology and genetic variation
in NoV strains circulating in China.
Method: Real-time RT-PCR (qPCR) was performed for Norovirus detection. RT-PCR were used for genomic
amplification and sequencing. Genogroup and genotype were assigned using the NoV Noronet typing tool and the
strains were named according to the time of isolation. The phylogenetic analysis was conducted using MEGA 5.
Results: Of the 809 specimens, 193 (23.9 %) were positive for NoV, with GII.4 and GII.17 the most commonly
identified strains. Phylogenetic analysis confirmed the presence of five recombinant strains in Huzhou. Recombinants
GII.P13/GII.17 and GII.P12/GII.4 were newly detected in China. The GII.P13/GII.17 recombinant was first identified in
October 2014 and steadily replaced GII.Pe/GII.4 (GII.4 Sydney 2012) as the predominant circulating NoV genotype.
Conclusion: This is the first report of the detection of GII.17 in the Huzhou area and of a NoV genotype being detected
in greater numbers than GII.4. Furthermore, our results indicated that following the emergence of GII.17 in October
2014, it steadily replaced the previous circulating GII.4 Sydney2012 strain, which was the dominant circulating
genotype for the past 2 years. As norovirus are the important cause of nonbacterial gastroenteritis, continuous
and comprehensive study of the norovirus strains involved in large and cost-effective acute gastroenteritis would
help understanding the molecular epidemiology of norovirus infections and development of improved prevention and
control measures.
Background
Norovirus (NoV) is the leading cause of both outbreaks
and sporadic cases of acute gastroenteritis in children
and adults worldwide [1, 2]. Investigations of outbreaks
have shown that the majority of transmissions are by
direct contact with individuals carrying the virus, water,
aerosols, contaminated food, and due to environmental
contamination [3].
NoV is a member of the family Caliciviridae and has
a positive-sense, single-stranded RNA genome (7.6 kb).
Genetically, NoV has been classified into six gen-
ogroups (genogroup I [GI] to genogroup VI [GVI]), of
which GI, GII, and GIV can infect humans [4]. The
genogroups are further classified into 9 GI, 22 GII, and
2 GIV genotypes [4–6].
NoV genotype GII.4, which evolves rapidly, is associ-
ated with most NoV outbreaks and sporadic cases. New
GII.4 variants emerge every 2–3 years and become the
dominant strains during the new season [7]. These vari-
ants seem to have greater epidemiological fitness than
other genotypes. Since 2008, at least three GII.4 variants
have been circulating in the Huzhou area, China [8].
From early 2008 to late 2014, almost all outbreaks and the
majority of sporadic cases in Huzhou were caused by
GII.4. A new recombinant GII.P13/GII.17 was detected in
sporadic cases in November 2014, and rapidly came to
predominate over GII.4 in terms of number of cases. Here,
we describe the emergence of GII.P13/GII.17 NoV strains
and characterize the molecular epidemiology of NoV in-
fection between February 2014 and February 2015.
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Results
Features of NoV-associated sporadic acute gastroenteritis
in Huzhou, 2014–2015
NoVs were continuously detected throughout the year.
From March 2014 to February 2015, 809 stool speci-
mens collected from sporadic cases of acute gastroenter-
itis were received for NoV detection. NoV infection was
found in all age groups tested (≤10y, 11–20y, 21–30y,
31–40y, 41–50y, 51–60y, and >60y). Of the 809 speci-
mens, 193 (23.9 %) were positive for NoVs. Among
these, GII NoVs comprised the greatest proportion, ac-
counting for 93.3 % (180/193), with GII.4 and GII.17 the
most commonly identified strains, GI NoVs comprised
6.2 % (12/193), and GI-GII co-infections comprised only
0.5 % (1/193). The highest NoV detection rate was dur-
ing October 2014 and February 2015 (Fig. 1). However,
GI NoV infection peaked from April to June 2014.
Genotyping of NoVs
NoV-positive samples were genotyped by sequencing of
regions A and C. Of the 193 norovirus positive strains,
101 were genotyped using both the capsid and polymer-
ase genes, while 10 were genotyped using the polymer-
ase gene alone, and 3 were genotyped using the capsid
gene alone (Table 1). The most prevalent NoV genotypes
were GII.Pe/GII.4 (38.6 %) and GII.P13/GII.17 (36.8 %).
The GII.Pe/GII.4 genotype has been reported to predom-
inate globally in many recent surveillance studies of NoV
epidemics. The extremely high percentage of GII.17 was
reported for the first time in the Huzhou area.
The incidence of sporadic acute gastroenteritis was
higher during the 2014–2015 seasonthan previously (data
not shown). An examination of the distribution of the de-
tected NoV variants over time highlights that the emergent

























Fig. 1 a Temporal distribution of NoV-positive cases in Huzhou, 2014–2015. Monthly detection of NoV in Huzhou from March 2014 to February
2015. b Temporal distribution of GII.4 and GII.17 in Huzhou, 2014–2015. Monthly distribution of genotype GII.4 and GII.17 in Huzhou from March
2014 to February 2015
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Sydney 2012) as the predominant NoV in circulation in
the Huzhou area (Fig. 1), which has not occurred previ-
ously. In February 2015, all positive isolates that could
be genotyped were GII.P13/GII.17. This is the first re-
port of (i) detection of GII.P13/GII.17 in the Huzhou
area, China, and (ii) of a NoV genotype being detected
in greater numbers than GII.4.
Recombinant strains
Of the114 strains genotyped using two genes, 89 strain-
scorresponded to suspected intergenotype recombinant
strains (discordant capsid and polymerase genotypes).
Notable among these were GII.Pe/GII.4 (n = 44, 49.4 %),
GII.P13/GII.17 (n = 42, 47.2 %), GII.P12/GII.4, GII.P7/
GII.6, and GI.Pb/GI.6 (n = 1, 1.1 %). PCR of the ORF1/
ORF2 junction region confirmed the recombination of
these strains. Among them, recombinants GII.Pe/GII.4,
GII.P7/GII.6, and GI.Pb/GI.6 have been reported previ-
ously [8]. Recombinants GII.P13/GII.17 and GII.P12/
GII.4 were newly detected in China (Table 1).
Phylogenetic analysis of GII recombinant strains
The identification of discordant genotype clustering for
the partial polymerase and capsid gene sequences of
NoV strains resulted in detection of two new recombi-
nants in the Huzhou area: GII.P13/GII.17 and GII.P12/
GII.4 (Fig. 2). Partial capsid gene sequence analysis of
GII.17 NoVs showed that strains associated with GII.P13
polymerase segregated in a distinct cluster. This recom-
binant was first identified in October 2014, and there-
after rapidly became dominant type. Analysis of the
GII.P12/GII.4 recombinant showed that it harbored a
GII.12 polymerase gene and a GII.4 capsid gene. This
strain was initially, and only, identified in January 2015.
The recombinant strain GII.Pe/GII.4 is also named GII.4
Sydney 2012, which was first identified in 2012 and has
been the dominant circulating strain in the Huzhou area
for the past 2 years.
Discussion
NoV is a leading cause of outbreaks and sporadic cases
of gastroenteritis in individuals of all ages [9, 10] world-
wide, including in the Huzhou area, China. In the
present study, we analyzed NoV-associated sporadic
acute gastroenteritis in the Huzhou area between March
2014 and February 2015. Our data showed that NoV cir-
culates at high rates, and exhibits considerable genetic
diversity. The circulation peak occurred during the win-
ter–spring seasons. The circulating genotypes found in
the present study differ from results obtained previously,
in which GII.4 was the dominant circulating genotype,
with other genotypes being detected at low frequencies
[8]. Following the emergence of GII.17 in October 2014,
it steadily replaced the previous circulating GII.4 Syd-
ney2012 strain. GII.17 became the most commonly de-
tected NoV strain in the Huzhou area by February 2015.
Interestingly, young (≤10y) and old (>60y) ones are more
likely to be infected with GII.4. While GII.17 prone to
infect people aged from 21-50y. This is the first report
of the detection of GII.17 in the Huzhou area and of a
NoV genotype being detected in greater numbers than
GII.4. These findings suggest that GII.17 has a selective
advantage compared to GII.4 Sydney2012, possibly by
accumulation of mutation in the past few years.
The periodic emergence of GII.4 NoV strains has been
previously documented [11–13]. Since the late 1990s,
the molecular epidemiology of NoV-associated acute
gastroenteritis has been characterized by the occurrence
and periodic emergence of novel variants of the NoV
GII.4 lineage [12, 14, 15]. Most NoV outbreaks world-
wide are caused by NoV variants of the GII.4 lineage.
When a new GII.4 variant is identified it often then be-
comes predominant and is associated with an increase in
disease activity [7, 16].
Table 1 NoV detected in the Huzhou area, China, 2014–2015
NoV genotype Number Percentage
GI





ORF2b GI.2 2 1.8
GII












ORF2b GII.17 1 0.9
Total 114 100
Distribution of genotypes according to PCR of the polymerase genes (ORF1)
and capsid genes(ORF2)
aORF2 not determined (negative PCR of the capsid gene)
bORF1 not determined (negative PCR of the polymerase gene)
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GII.4 NoV has been circulating in the Huzhou area
since 2008, when monitoring of NoV was initiated. Since
that time, at least three variants have been identified:
2006b, New Orleans 2009, and Sydney 2012 [8]. GII.4
2006b variants were detected in 2008 and 2009. Follow-
ing the first detection of the GII.4 New Orleans 2009
variant in December 2010, they rapidly replaced GII.4
2006b and predominated from 2010 to 2011. From 2012
to the present, GII.4 Sydney 2012 accounted for the ma-
jority of both sporadic cases and outbreaks of NoV-
associated acute gastroenteritis. The GII.4 Sydney-2012
variant (a recombinant of strains GII.Pe/GII.4) was first
identified in Australia in March 2012. By late 2012, various
countries worldwide had reported higher incidences of
NoV outbreaks or illness than before, most of these were
caused by the GII.4 Sydney-2012 variant [17–19]. In the
Huzhou area, the GII.4 Sydney-2012 variant was first iden-
tified in November 2012, and became the predominant
GII.4 variant soon thereafter. This variant caused several
outbreaks in the Huzhou area between 2012 and 2014 [8].
To the best of our knowledge, there are few reports of
the relative contribution of NoVs to sporadic acute
gastroenteritis. Boga et al. [20] indicated that NoVs were
less common than rotaviruses, Campylobacter spp., and
Salmonella spp., but more frequent than astroviruses,
adenoviruses, and Yersinia spp., as causes of sporadic
acute gastroenteritis. Our results indicate that NoV plays
an important role in sporadic acute gastroenteritis, as
evidenced by the 23.9 % (193/809) positive rate. Previ-
ously, most such cases were caused by NoV GII.4, with
other genotypes being detected at lower frequencies.
Following the emergence of GIIP13/GII.17, GII.4 has
been steadily replaced. GIIP13/GII.17 had replaced GII.4
by February 2015, becoming the predominant NoV
genotype in the Huzhou area.
NoV GII.17 has been reported in children with gastro-
enteritis in Central and South America [21–23]), Korea
[24], and Thailand [25]. Kiulia reported that NoV GII.17
predominates in selected surface water sources in Kenya
[26]. GII.17 has been in existence for many years at a
low frequency. However, it emerged in the Huzhou area,
and now causes a greater number of cases than GII.4. It
is the same condition in other part of China and also in


























































































































Fig. 2 Phylogenetic analyses of recombinant GII NoV strains originating from sporadic acute gastroenteritis patients in Huzhou, 2014–2015.
Phylogenetic analyses of the partial RdRp (a) and capsid (b) regions of the GIIPe/GII.4, GII.P13/GII.17, and GII.P12/GII.4 recombinants from sporadic
acute gastroenteritis patients in Huzhou, 2014–2015, compared to representative strains. NoV strains detected in the Huzhou area are denoted by
bold typeface
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acid of the new variant changed, especially in the pro-
truding P2 domain [29, 30]. Why did GII.17 emerge sud-
denly? Did this genotype accumulate greater fitness, or
simply undergo recombination event(s)? The answers to
these questions are unknown. The biological and epi-
demiological success of GII.4 is, at least in part, influ-
enced by mutations in the hypervariable P2 domain that
affects the antigenic profile of the virus [31–34], which
can lead to worldwide strain replacement events [18]. It
is interesting to ponder whether the GIIP13/GII.17 re-
combinant could become the next epidemic strain like
previous G11.4 strains and lead to worldwide strain re-
placement and an acute gastroenteritis pandemic?
The limitation of this study was the short monitoring
period. Specimens were collected over a 1-year period,
so whether or not GII.17 will continue to circulate is un-
clear. However, it is certain that GII.17 has emerged in
the Huzhou area, and now outnumbers GII.4 for the
first time.
Conclusions
In summary, this is the first report of the detection of
GII.17 in the Huzhou area and of a NoV genotype being
detected in greater numbers than GII.4. The results
showed that norovirus circulating in the Huzhou area
have high diversity and new recombinants continue to
emerge. Furthermore, our results indicated that follow-
ing the emergence of GII.17 in October 2014, it steadily
replaced the previous circulating GII.4 Sydney2012
strain, which was the dominant circulating genotype for
the past 2 years. As norovirus are the important cause of
nonbacterial gastroenteritis, continuous and comprehen-
sive study of the norovirus strains involved in large and
cost-effective acute gastroenteritis would help under-
standing the molecular epidemiology of norovirus infec-




Institutional review board approval was not requested,
as this study was part of a routine laboratory-based in-
vestigation. No human experimentation was conducted;
all experiments were carried out using norovirus strains.
The only human materials used were stool samples that
had been sent to our laboratory for routine virological
diagnosis of gastroenteritis. The results reported are as-
sociated with norovirus strains, with no patient informa-
tion used.
Specimen collection
This study was conducted at the First People’s Hospital in
Huzhou, Huzhou, China as part of the regional NoV
gastroenteritis surveillance program. Between March 2014
and February 2015, a total of 809 fecal samples were col-
lected from outpatients with clinical symptoms of acute
gastroenteritis. Acute gastroenteritis was defined as the
presence of one or more of the following symptoms: nau-
sea, vomiting, and/or diarrhea. Fecal samples were col-
lected during the acute phase of infection. Acute phase
means the period of time when patient have the above
symptoms. All samples were obtained in a sterile con-
tainer and were transported to our laboratory for immedi-
ate storage at −70 °C prior to analysis.
Norovirus detection
Fecal samples were prepared as 10 % suspensions in
phosphate-buffered saline (pH 7.4). Total nucleic acid
was extracted from a 200 μL aliquot of fecal suspension
using a QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
The RNA extracts were subjected directly to reverse
transcription (RT)-PCR (Polymerase Chain Reaction) or
stored at −70 °C. Real-time RT-PCR (qPCR) was per-
formed using primers and probes described previously
[8]. RT-qPCR was carried out using a One Step Prime-
Script RT-PCR Kit (Perfect Real Time) (TaKaRa, Dalian,
China). The reaction was conducted with an initial RT step
at 42 °C for 30 min, followed by 95 °C for 5 min and 40 cy-
cles of qPCR at 95 °C for 5 s and 55 °C for 35 s.
Genomic amplification and sequencing
Samples that tested positive for NoV by RT-qPCR were
analyzed using two PCRs directed at region A of ORF1
(the 3′end of the polymerase gene ) using the primers
JV12/ JV13, and at region C in ORF2 ( the 5′ end of the
capsid gene ) using the primers G1SKF/G1SKR for GI
and G2SKF/G2SKR for GII [35, 36]. RT-PCR was carried
out using a One Step RNA PCR Kit (TaKaRa) with the
following amplification conditions: RT at 50 °C for
30 min and denaturation at 95 °C for 3 min, followed by
35 cycles of 30 s at 94 °C, 30 s at 48 °C, and 30 s at 72 °C.
A final extension step for 10 min at 72 °C was performed.
After amplification, the PCR products were visualized by
agarose gel electrophoresis. To analyze recombinant
strains (capsid and polymerase of different genotypes), se-
quences covering the overlap between ORF1 and ORF2
were amplified by RT-PCR using primers JV12 and
G1SKR/G2SKR when phylogenetic analyses indicated dis-
cordant clustering for partial sequences of the polymerase
and capsid genes in the same sample. RT-PCR was carried
out using a One Step RNA PCR Kit (TaKaRa). RT-PCR
conditions were as follows: RT at 50 °C for 30 min and de-
naturation at 95 °C for 2 min, followed by 35 cycles of 30 s
at 94 °C, 30 s at 48 °C, and 1 min at 72 °C. A final exten-
sion step was performed for 10 min at 72 °C. The PCR
products were purified using a QIAquick PCR purification
kit (Qiagen, Leusden, The Netherlands) according to the
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manufacturer’s instructions. The amplicons were se-
quenced by TaKaRa Biotechnology (Dalian).
Genotyping and phylogenetic analysis
Genogroup and genotype were assigned using the NoV
Noronet typing tool (http://www.rivm.nl/mpf/norovirus/
typingtool) [6] and the strains were named according to
the time of isolation. The phylogenetic analysis was con-
ducted using MEGA 5 [37]. Phylogenetic trees with
1000 bootstrap replicates were generated using the
neighbor-joining method by employing molecular evolu-
tionary genetics analysis (MEGA), version 5.0. Reference
strains were downloaded from GenBank.
Nucleotide sequence accession numbers
The GenBank accession numbers for sequences obtained in
this study are KP995319-KP995341, KR361528-KR361548.
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